Molecular Rotors Detect the Formation and Conversion of α-Synuclein Oligomers
Source abstract
Abstract
α-Synuclein is an intrinsically disordered protein that forms amyloids in Parkinson's disease. Currently, detection methods predominantly report on the formation of mature amyloids but are weakly sensitive to the early stage, toxic oligomers. Molecular rotors are fluorophores that sense changes in the viscosity of their local environment. Here, we monitor α-synuclein oligomer formation using the fluorescence lifetime of molecular rotors. We detect oligomer formation and conversion into amyloids for wild-type and two α-synuclein variants, the pathological mutant A30P and ΔP1 α-synuclein, which lacks a master regulator region of aggregation (residues 36-42). We report that A30P α-synuclein shows a rate of oligomer formation similar to that of wild-type α-synuclein, whereas ΔP1 α-synuclein shows delayed oligomer formation. Additionally, both variants demonstrate a slower conversion of oligomers into amyloids. Our method provides a quantitative approach to unveiling the complex mechanism of α-synuclein aggregation, which is key to understanding the pathology of Parkinson's disease.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Parkinson's Disease Mechanisms and Treatments · Carbohydrate Chemistry and Synthesis · Synthetic Organic Chemistry Methods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Molecular Sciences Research Hub
Imperial College London
Institute of Chemical Biology, Molecular Sciences Research Hub
Funding
Research Councils UK · UK Research and Innovation · Alzheimer???s Research UK
References (37)
Show source-provided references
1. 10.3389/fncel.2019.0017510.3389/fncel.2019.00175 ↗
2. 10.1101/cshperspect.a03387810.1101/cshperspect.a033878 ↗
3. 10.1038/nrm381010.1038/nrm3810 ↗
4. 10.1016/j.cell.2012.03.03710.1016/j.cell.2012.03.037 ↗
5. 10.1016/S0022-2836(02)00735-010.1016/S0022-2836(02)00735-0 ↗
6. 10.1021/acschemneuro.8b0057910.1021/acschemneuro.8b00579 ↗
7. 10.1111/jnc.1217510.1111/jnc.12175 ↗
8. 10.1371/journal.pone.019605610.1371/journal.pone.0196056 ↗
9. 10.1038/nature1032410.1038/nature10324 ↗
10. 10.1021/jz500177510.1021/jz5001775 ↗
11. 10.1074/jbc.M21013620010.1074/jbc.M210136200 ↗
12. 10.1038/s41531-019-0095-310.1038/s41531-019-0095-3 ↗
13. 10.1016/j.jchemneu.2010.12.00110.1016/j.jchemneu.2010.12.001 ↗
14. 10.1093/brain/awad15010.1093/brain/awad150 ↗
15. 10.4103/1735-1995.18198910.4103/1735-1995.181989 ↗
16. 10.1111/jnc.1481010.1111/jnc.14810 ↗
17. 10.1073/pnas.142120411210.1073/pnas.1421204112 ↗
18. 10.1021/acs.jpcb.5b0509910.1021/acs.jpcb.5b05099 ↗
19. 10.1098/rsos.16069610.1098/rsos.160696 ↗
20. 10.1016/j.nbd.2022.10596610.1016/j.nbd.2022.105966 ↗
21. 10.1101/2024.02.17.58069810.1101/2024.02.17.580698 ↗
22. 10.1039/C7CP03571C10.1039/C7CP03571C ↗
23. 10.1039/C8SM01633J10.1039/C8SM01633J ↗
24. 10.1021/ar300053p10.1021/ar300053p ↗
25. 10.1021/jp805822c10.1021/jp805822c ↗
26. 10.4161/pri.2812510.4161/pri.28125 ↗
27. 10.1529/biophysj.107.12015410.1529/biophysj.107.120154 ↗
28. 10.1016/j.cell.2012.03.03710.1016/j.cell.2012.03.037 ↗
29. 10.1038/s41593-022-01140-310.1038/s41593-022-01140-3 ↗
30. 10.1073/pnas.97.2.57110.1073/pnas.97.2.571 ↗
31. 10.1038/s41598-022-10789-610.1038/s41598-022-10789-6 ↗
32. 10.1038/s41594-020-0384-x10.1038/s41594-020-0384-x ↗
33. 10.1038/s41467-022-32687-110.1038/s41467-022-32687-1 ↗
34. 10.1021/jacs.4c0226210.1021/jacs.4c02262 ↗
35. 10.1074/jbc.M80074720010.1074/jbc.M800747200 ↗
36. 10.1016/j.ijbiomac.2016.12.01110.1016/j.ijbiomac.2016.12.011 ↗
37. 10.3389/fnins.2022.88148010.3389/fnins.2022.881480 ↗